Tradestie Institutional Equity Comparison Engine

ATXS vs ARVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATXS Overall Edge

ATXS Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astria Therapeutics, Inc. Common Stock (ATXS) driven by superior Momentum & Technical, Options & Structure while ARVN counters with relative strength in Valuation, Growth & Margin. Fundamentally, ATXS trades at N/M Forward P/E with -4830.6% operating margin (+0.0% YoY revenue) versus ARVN at 17.9x Forward P/E and -10.1% operating margin (-98.8% YoY). In options structure, ATXS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARVN
ATXS N/M vs ARVN 17.9x Fwd P/E
Growth & Margin Winner ARVN
Op Margin -4830.6% vs -10.1% ยท YoY +0.0% vs -98.8%
Momentum & Technical Winner ATXS
1Y +66.2% vs -33.4% ยท 52W Pos 93% vs 5%
Options & Structure Winner ATXS
UNCLASSIFIED (50th %ile IV) vs BREAKDOWN (25th %ile IV)
ATXS NASDAQ
Astria Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$12.58
+0.64% 1D
Market Cap $713.6M
1M Return -1.95%
1Y Return +66.18%
Forward P/E N/M
Unified AI Score
57.0 / 100 HOLD
Tech 40.0 Fund 45.0 Flow 50.0 Mom 42.4
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATXS +66.18% ARVN -33.4% Spread: +23.08 pp (ARVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ATXS TTM Op. Margin: -4830.6% ARVN TTM Op. Margin: -10.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATXS vs ARVN. Trailing 12-month operating profitability (ATXS -4830.6% vs ARVN -10.1%) and valuation multiples (ATXS N/M vs ARVN 17.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATXS (6) vs ARVN (4)
Institutional Metric ATXS ARVN Criterion Row Winner
Market Capitalization Scale $713.6M $449.9M Larger Scale ATXS
Trailing P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Forward P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Revenue Growth (YoY) Growth +0.0% -98.8% Higher Growth ATXS
Operating Margin (TTM) Profitability -4830.6% -10.1% Higher Margin ARVN
Net Profit Margin Profitability 0.0% -3.5% Higher Margin ATXS
Return on Equity (ROE) Capital Efficiency -43.1% -1.8% Higher ROE ARVN
52-Week Range Position Momentum 93% ($4โ€“$13) 5% ($6โ€“$15) Stronger Trend ATXS
Beta / 30D Volatility Risk Regime 1.26ฮฒ ยท 20% Vol 1.40ฮฒ ยท 66% Vol Lower Realized Risk ATXS
Unified Institutional Score Composite Signal 57.0 / 100 (HOLD) 52.9 / 100 (HOLD) Higher Composite ATXS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATXS vs ARVN Buy Guide
ATXS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATXS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATXS nor ARVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.